Sale!

DARS2 Gene Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) is a rare genetic disorder caused by mutations in the DARS2 gene. This condition is characterized by changes in the white matter of the brain, specifically affecting the brainstem and spinal cord, and is often associated with elevated lactate levels, indicating a disruption in cellular energy production. Symptoms can include difficulties with movement and coordination, muscle stiffness, and developmental delays, among others.

To diagnose this condition, a genetic test targeting the DARS2 gene can be performed. This test involves analyzing the DNA to identify mutations in the DARS2 gene that are responsible for LBSL. It is a crucial step for confirming the diagnosis, understanding the disease’s progression, and potentially guiding treatment options.

At DNA Labs UAE, this specialized genetic test for identifying DARS2 gene mutations associated with LBSL is available. The cost of the test is 4400 AED. Conducting the test in a reputable laboratory like DNA Labs UAE ensures accuracy and reliability of the results, providing essential information for patients and their families to manage the condition effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DARS2 Gene Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation Genetic Test

Are you looking for a genetic test for Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL)? DNA Labs UAE offers a comprehensive genetic test for the DARS2 gene, which is associated with this rare genetic disorder.

Test Details

The DARS2 gene is linked to Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL), a progressive neurological disorder that affects the brain, brainstem, and spinal cord. Our Next-Generation Sequencing (NGS) technology allows for the simultaneous analysis of multiple genes, including the DARS2 gene, in a single test. NGS technology is a rapid and cost-effective method for genetic diagnosis, as it can sequence large portions of the genome efficiently.

How the Test Works

The NGS genetic test for LBSL requires a DNA sample, usually obtained through a blood sample, from the individual suspected of having the disorder. Using NGS technology, we analyze the DARS2 gene and other relevant genes associated with LBSL. By identifying specific genetic mutations or variants in the DARS2 gene, our NGS test can confirm a diagnosis of LBSL.

Test Components and Price

The cost of the DARS2 Gene Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation Genetic Test is AED 4400.0. The test can be performed on blood or extracted DNA, or even just one drop of blood on an FTA card. The report will be delivered within 3 to 4 weeks.

Pre-Test Information

Prior to undergoing the DARS2 Gene Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation NGS Genetic DNA Test, it is recommended to provide the clinical history of the patient. Additionally, a Genetic Counselling session is advised to draw a pedigree chart of family members affected by LBSL.

Test Department and Doctor

The DARS2 Gene Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation Genetic Test is conducted by our Genetics department. The test is typically ordered by a Neurologist who specializes in neurological disorders.

Importance of Genetic Testing

Genetic testing, including NGS, is a crucial step in understanding the underlying cause of LBSL. It can provide valuable information for treatment and management strategies. It is important to note that genetic testing should be performed by medical professionals, such as geneticists or genetic counselors, who can interpret the results and provide appropriate counseling and support to individuals and families affected by LBSL.

Test Name DARS2 Gene Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DARS2 Gene Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DARS2 Gene Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation
Test Details

The DARS2 gene is associated with a rare genetic disorder called Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL). LBSL is a progressive neurological disorder that affects the brain, brainstem, and spinal cord.

NGS (Next-Generation Sequencing) is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the DARS2 gene, in a single test. NGS technology enables the rapid and cost-effective sequencing of large portions of the genome, making it a powerful tool for genetic diagnosis.

The NGS genetic test for LBSL involves obtaining a DNA sample, typically through a blood sample, from the individual suspected of having the disorder. The DNA is then sequenced using NGS technology to analyze the DARS2 gene and other relevant genes associated with LBSL.

By identifying specific genetic mutations or variants in the DARS2 gene, the NGS test can confirm a diagnosis of LBSL. This information is crucial for understanding the underlying cause of the disorder and can help guide treatment and management strategies.

It’s important to note that genetic testing, including NGS, is typically performed by medical professionals, such as geneticists or genetic counselors, who can interpret the results and provide appropriate counseling and support to individuals and families affected by LBSL.